Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02096289 · COMPLETED
Trial details
- NCT number
- NCT02096289
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.